Clinical Trials Browser

Phase 1 × Recruiting × HER2-positive Breast Cancer × Clear all

NCT05514717 2025-07-11

A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2

Phase 1 Recruiting

BreastGastrointestinalThoracic

HER2-positive Breast Cancer

NCT04332588 2025-05-29

Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRI

Phase 1 Recruiting

HER2-positive Breast Cancer